Cargando…
ODP264 An Unusual Etiology of Hypothyroidism and New-Onset Insulin-Dependent Diabetes: A Rare Side Effect of Opdivo
INTRODUCTION: Nivolumab, a monoclonal antibody targeting programmed cell death 1 receptor, is prescribed for many advanced cancers like malignant melanoma, non-small cell lung cancer, renal cell carcinoma (RCC), etc. with increased use of this medication, the incidence of immune-related side effects...
Autores principales: | Alchalabi, Halah, Udongwo, Ndausung, Albustani, Safa, Amin, Tasnuva, Fareen, Nusha, Chineyemba, Praise, Holland, Soemiwati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625338/ http://dx.doi.org/10.1210/jendso/bvac150.896 |
Ejemplares similares
-
An Unusual Etiology of Hypothyroidism and New-Onset Insulin-Dependent Diabetes: A Rare Side Effect of Nivolumab
por: Alchalabi, Halah, et al.
Publicado: (2022) -
ODP273 Schmidt Syndrome Causing Multiorgan Failure
por: Hayes, Clarissa, et al.
Publicado: (2022) -
ODP265 Bph, Androgenic Alopecia, and Acne - Markers of Progesterone Deficiency
por: Kalinchenko, Svetlana, et al.
Publicado: (2022) -
ODP277 Urinary Concentrations of Polycyclic Aromatic Hydrocarbons and Childhood Obesity
por: Kim, Shin-Hye, et al.
Publicado: (2022) -
ODP269 Impacts of Gestational Bisphenol A Exposure on Adult Hypothalamic Neurogenesis
por: Feighan, Kira, et al.
Publicado: (2022)